RNTX

Rein Therapeutics
RNTX

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $3.21M invested in Rein Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

45% less capital invested

Capital invested by funds: $5.86M → $3.21M (-$2.64M)

87% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 15

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.5K
2
+$7.61K
3
+$5K
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.44K
5
Osaic Holdings
Osaic Holdings
Arizona
+$820

Top Sellers

1
-$62.7K
2
-$38K
3
-$24.3K
4
Northern Trust
Northern Trust
Illinois
-$24K
5
GPFA
Game Plan Financial Advisors
Ohio
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.97M
2
$561K
3
$309K
4
$161K
5
$105K
6
$52.9K
7
$25K
8
$9K
9
$7.85K
10
$5K
11
$3.77K
12
$2.96K
13
$2.96K
14
$448
15
$433
16
$55
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2